Skip to content
OpenCapital
Get started

Veracyte VCYT Free cash flow margin

Free cash flow margin at other companies

Guardant Health logo
Guardant HealthGH
-22%-6.7pp
Natera, Inc. logo
Natera, Inc.NTRA
4.2%-0.5pp
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
13.8%-0.2pp
Revvity logo
RevvityRVTY
17%-1.9pp
Labcorp Holdings logo
Labcorp HoldingsLH
9.8%+1.0pp
Quest Diagnostics logo
Quest DiagnosticsDGX
11.8%+1.4pp

Other financials

Income statement

See full
Revenue$139.1M+21.5%
Gross profit$101.2M+27.2%
Operating income$22.6M+680%
Net income$28.7M+307%
EPS (diluted)$0.35+289%

Balance sheet

See full
Cash & equivalents$264.8M+41.0%
Total debt$39.3M-22.1%
Total equity$1.3B+12.5%
Total assets$1.4B+9.2%

Cash flow

See full
Operating cash flow$35.2M+557%
CapEx$3.0M+62.8%
Free cash flow$32.3M+810%

Valuation

See full
Market cap$4.28B+10.7%
Enterprise value$4.05B+7.4%
P/E48.6×-68.3×
P/S7.9×-0.4×

Profitability

See full
Gross margin70.9%+2.9pp
Operating margin14.3%+9.2pp
Net margin16.2%+9.1pp

Returns & leverage

See full
Return on equity6.9%+4.1pp
Debt / equity0×0.0×
Current ratio9.3×+4.2×

Where this comes from

Calculated from Veracyte’s reported figures.

free cash flow/total revenue=28.7%

Based on trailing twelve months.

The official record: Veracyte’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Veracyte's free cash flow margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Veracyte's free cash flow margin?
Veracyte (VCYT) reported free cash flow margin of 28.7% in Q1 2026.
How has Veracyte's free cash flow margin changed year-over-year?
Veracyte's free cash flow margin increased by 69.4% year-over-year, from 16.9% to 28.7%.
What is the long-term trend for Veracyte's free cash flow margin?
Over 2 years (2023 to 2025), Veracyte's free cash flow margin has grown at a 60.6% compound annual growth rate (CAGR), from 9.5% to 24.5%.
What does free cash flow margin mean?
Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.